MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Cancer J
Autors principals: de la Puente, P, Muz, B, Jin, A, Azab, F, Luderer, M, Salama, N N, Azab, A K
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Letter to the Editor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4771970/
https://ncbi.nlm.nih.gov/pubmed/26918363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2016.7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars